Navigation Links
Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
Date:12/20/2007

OAKLAND, Calif., Dec. 20 /PRNewswire/ -- The largest study to examine the effect of depression on HIV treatment found that depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures, but that effective antidepressant medication can reverse this outcome, according to a study by the Kaiser Permanente Division of Research and the Group Health Cooperative published in the current online issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS).

The study looked at 3,359 HIV-infected patients from seven Kaiser Permanente regions nationwide and Group Health in 2000 to 2003 to measure the effects of depression -- with and without selective serotonin reuptake inhibitors (SSRI) use -- on adherence and changes in viral and immunologic control in patients starting a new highly active antiretroviral therapy (HAART) regimen.

The researchers studied the patients' HAART adherence, viral loads, and changes in CD4 T-cell counts over a 12-month period. The study found that depressed patients -- 42 percent of the patient group -- had a lower adherence rate and worse viral therapy response compared to non-depressed patients. But depressed patients who were prescribed SSRI medication and adhered to it had the same outcomes as non-depressed patients.

"The take-home point of this study is that depression carries a worse prognosis for HAART in HIV patients. However, we also found that SSRIs can reverse this and improve outcomes for HIV-depressed patients," said Michael A. Horberg, MD, MAS, FACP, Director of HIV/AIDS for Kaiser Permanente and the lead author on the study. "HIV and depression often go hand in hand. If you are HIV-infected, you should be screened regularly for depression, and if you are depressed and you are going to go on HAART, it's very worthwhile to treat your depression."

Kaiser Permanente and Group Health are the second largest provider of HIV care in the United State
'/>"/>

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2008)...lative therapy with HALO device leads to 100% pati..., SUNNYVALE, Calif., May 20 /- BARRX...ting Barrett,s esophagus, today announced the,publ...t a 100% eradication,rate for early esophageal can...esection followed by ablation therapy with the HAL...
(Date:5/20/2008)...N, May 20 /PRNewswire-USNewswire/ -- Fuisz Tobacco...cal study comparing the,absorption of nicotine fro...rip and the use of a nicotine 2mg chewing gum -- t...com/cgi-bin/prnh/20080115/CLTU066 ), The results...y for the,Fuisz Tobacco strip. A Fuisz Tobacco str...
(Date:5/19/2008)..., Md., May 19 /PRNewswire-USNewswire/ -- On Thursd...mpany of the Year at the annual,Technology Council...e,state,s technology leaders and organizations., ... , "All the members of the Sanaria team go to wor... a vaccine that will prevent millions of deaths,fr...
(Date:5/19/2008)...her with Nektar Therapeutics present preliminary P... pneumonia in intubated and mec..., May 19 /- Bayer HealthCar... ), today presented positive,preliminary Phase II ...cin,Inhale at the American Thoracic Society (ATS) ...
Breaking Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 2Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 3Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Maryland's Emerging Company of the Year Award 2Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 1Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 2Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 3Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder 2108 1Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder 2108 2Kiwa Bio Tech Completes 1st Stage of Shandong Factory Upgrading 859 1Kiwa Bio Tech Completes 1st Stage of Shandong Factory Upgrading 859 2Engineered eggshells to help make hydrogen fuel 575 1Engineered eggshells to help make hydrogen fuel 575 2Engineered eggshells to help make hydrogen fuel 575 3
(Date:5/20/2008)...adrenal masses seen on abdominal CT scans of low-r...eed any imaging follow-up, according to a large st...use incidental adrenal lesions are seen in about 5...tudy included 973 patients with 1,049 adrenal mass...uspicion of a hormonally active adrenal mass, said...
(Date:5/20/2008)... clinical settings, DNA microarrays are currently ...ion on formalin-fixed paraffin-embedded tissues is...lar markers for identifying the prognosis of gastr... a team led by Professor Zhong-Sheng Zhao, is desc...il 7, 2008 in the World Journal of Gastroenterolog...
(Date:5/20/2008)...doscopy is a well accepted tool for evaluation of ...However, it has some limitations due to restricted...residual material. Several forms of preparation (e...nts) have been tried to improve the quality of the...tocol has been recommended for bowel preparation f...
(Date:5/20/2008)...orectal signet ring cell carcinoma is a rare but d...n 96% of signet ring cell carcinomas arise in the ...organs. Therefore, a secondary infiltration or met...efore a definite diagnosis of primary colorectal s...This research, performed by a team led by Professo...
Breaking Medicine News(10 mins):Health News:How does sodium phosphate combined with bisacodyl affect small intestine? 2
...Investigation and the September issue of Nature Re...ersity have reported that a new drug helps in redu...acks by improving the blood flow in diseased arter...was found to reactivate a key enzyme, damaged by f...
...ak in the northeastern Nigerian state of Borno. He...d.// Cholera is an infectious disease that spreads...vernment has sent medical teams to deal with the c...ffected are women and children. Alhaji Buba Umar, ...
...day life contain mind-boggling cocktail of differe...rs, hormone problems and skin cancers.// Every day...to her body in the form of cosmetics and toiletrie...ion of Daily Mail. Most beauty products contain c...
... a panel of outside experts to review the safety o...mplaints that the fillings may cause health proble...to suggest that the fillings were dangerous in doz...safety of mercury in the silver fillings, and the ...
Other Medicine News:Health News:A New Drug That Could Revolutionize Management Of Heart Disease 2
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: